股本结构

单位:万股
公告日期 2025-11-04 2025-11-04 2025-08-05 2025-08-05 2025-04-29 2025-05-01
证券总股本 2271.14 2270.43 2228.90 2222.11 2220.33 2218.77
普通股本 2271.14 2270.43 2228.90 2222.11 2220.33 2218.77
优先股 未披露 236.98 未披露 236.98 未披露 236.98
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-10-30 2025-09-30 2025-08-01 2025-06-30 2025-04-24 2025-03-31
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2025-11-04 2271.14 未披露 定期报告 2025-10-30
2025-11-04 2270.43 236.98
更多>>
From June 30, 2025 to September 30, 2025 Issuance of common stock under equity plans
2025-09-30
2025-08-05 2228.90 未披露 定期报告 2025-08-01
2025-08-05 2222.11 236.98
更多>>
From March 31, 2025 to June 30, 2025 Issuance of common stock under equity plans
2025-06-30
2025-04-29 2220.33 未披露 定期报告 2025-04-24
2025-05-01 2218.77 236.98
更多>>
From December 31, 2024 to March 31, 2025 Issuance of common stock under equity plans
2025-03-31
2025-02-26 2208.02 未披露 定期报告 2025-02-21
2025-02-26 2200.47 236.98
更多>>
From December 31, 2023 to December 31, 2024 Issuance of common shares in equity offerings, excluding to related parties, net of transaction costs Sale of warrants and common shares to related parties and exercise of common stock options, net of transaction costs
2024-12-31
2024-10-31 2181.04 未披露 定期报告 2024-10-28
2024-10-31 2180.64 236.98
更多>>
From June 30, 2024 to September 30, 2024 Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2024-09-30
2024-08-07 2171.27 未披露 定期报告 2024-08-02
2024-08-07 2170.09 236.98
更多>>
From March 31, 2024 to June 30, 2024 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2024-06-30
2024-05-07 2131.15 未披露 定期报告 2024-05-03
2024-04-29 2128.46 未披露 定期报告 2024-04-22
2024-05-07 2068.47 236.98
更多>>
From December 31, 2023 to March 31, 2024 Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs Sale of warrants to related parties in equity offerings, exercise of common stock options, and restricted stock vesting, net of transaction costs
2024-03-31
2024-03-20 2064.74 未披露
更多>>
Common stock offered 750,000 shares by the company
2024-03-21
2024-02-28 1989.74 未披露 定期报告 2024-02-16
2024-02-28 1987.54 236.98
更多>>
From December 31, 2022 to December 31, 2023 Issuance of common and preferred shares in equity offerings, excluding to related parties, net of transaction costs Sale of warrants and common shares to related parties and exercise of common stock options, net of transaction costs
2023-12-31
2023-11-06 1974.26 未披露 定期报告 2023-11-01
2023-10-02 1971.93 未披露
更多>>
Common stock offered 1,248,098 shares by the company
2023-10-03
2023-11-06 1849.42 236.98
更多>>
From June 30, 2023 to September 30, 2023 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2023-09-30
2023-08-08 1847.12 未披露 定期报告 2023-08-03
2023-08-08 1845.90 236.98
更多>>
From March 31, 2023 to June 30, 2023 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2023-06-30
2023-05-09 1828.92 未披露 定期报告 2023-05-05
2023-05-09 1828.31 236.98
更多>>
From December 31, 2022 to March 31, 2023 Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2023-03-31
2023-02-23 1813.80 未披露 定期报告 2023-02-20
2023-02-23 1810.25 236.98
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common and preferred shares in equity offerings, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2022-12-31
2022-12-23 1714.78 236.98
更多>>
Series B Convertible Preferred Stock offered by the company 400,000 shares Common stock offered by the company 44,444 shares
2022-12-23
2022-02-24 1710.34 196.98
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2021-12-31
2021-11-04 1709.71 未披露 定期报告 2021-11-02
2021-11-04 1686.02 196.98
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Exercise of common stock options
2021-09-30
2021-08-05 1660.00 未披露 定期报告 2021-07-30
2021-08-05 1659.95 196.98
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs
2021-06-30
2021-05-06 1658.46 未披露 定期报告 2021-04-30
2021-04-30 1648.71 未披露 定期报告 2021-04-01
2021-05-06 1606.32 196.98
更多>>
From December 31, 2020 to March 31, 2021 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Exercise of common stock options
2021-03-31
2021-02-25 1602.47 未披露 定期报告 2021-02-19
2021-02-25 1550.81 196.98
更多>>
From December 31, 2019 to December 31, 2020 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2020-12-31
2020-11-05 1546.65 196.98
更多>>
From June 30, 2020 to September 30, 2020 Exercise of common stock options
2020-09-30
2020-08-06 1543.81 196.98
更多>>
From March 31, 2020 to June 30, 2020 Exercise of common stock options
2020-06-30
2019-11-06 1542.92 196.98
更多>>
from June 30, 2019 to September 30, 2019 Exercise of common stock options
2019-09-30
2019-08-07 1542.63 196.98
更多>>
From March 31, 2019 to June 30, 2019 Exercise of common stock options
2019-06-30
2019-04-30 1541.84 未披露 定期报告 2019-04-15
2019-05-08 1541.71 196.98
更多>>
from December 31, 2018 to March 31, 2019 Exercise of common stock options
2019-03-31
2019-02-27 1541.71 未披露 定期报告 2019-02-21
2019-02-27 1540.90 196.98
更多>>
from December 31, 2017 to December 31, 2018 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
2018-12-31
2018-11-06 1539.33 196.98 定期报告 2018-09-30
2018-08-07 1536.66 未披露 定期报告 2018-08-02
2018-08-07 1536.54 196.98 定期报告 2018-06-30
2018-05-08 1425.07 196.98 定期报告 2018-03-31
2018-03-13 1422.76 196.98
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common and preferred shares in equity offerings, net of transaction costs
2017-12-31
2017-11-09 1249.57 196.98 定期报告 2017-09-30
2017-08-10 1249.57 未披露 定期报告 2017-06-30
2017-05-11 1216.74 未披露 定期报告 2017-03-31
2017-03-31 1216.74 未披露 定期报告 2017-03-24
2017-03-31 1195.19 未披露
更多>>
from December 31, 2015 to December 31, 2016 Conversion of convertible notes and related accrued interest to common stock Retirement of restricted stock Acquisition of Synta Issuance of shares to financial advisors in connection with Merger Issuance of restricted common shares Issuance of common shares in equity offering, net of transaction costs
2016-12-31
2016-11-14 1157.01 未披露 定期报告 2016-09-30
2016-07-25 393.73 未披露
更多>>
On July 22, 2016, prior to the closing of the merger, Synta completed a one-for-35 reverse stock split. As a result of the reverse stock split, every 35 shares of Synta common stock outstanding immediately prior to the merger were combined and reclassified into one share of Synta common stock. n connection with the merger, Synta changed its name to Madrigal Pharmaceuticals, Inc. The combined company will commence trading on a post-reverse stock split basis upon the opening of trading on July 25, 2016 on the NASDAQ Global Market under the symbol “MDGL”.
2016-07-25
2016-07-20 13780.47 未披露 定期报告 2016-06-30
2016-03-15 13780.64 未披露 定期报告 2016-03-10
2015-11-05 13778.86 未披露
更多>>
From December 31, 2014 to September 30, 2015 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Forfeitures of restricted common shares
2015-09-30
2015-08-06 13644.24 未披露 定期报告 2015-08-03
2015-08-06 13407.07 未披露 定期报告 2015-06-30
2015-04-30 13442.07 未披露 定期报告 2015-04-16
2015-03-12 10912.07 未披露
更多>>
from December 31, 2013 to December 31, 2014 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Forfeitures of restricted common shares Exercise of stock options
2014-12-31
2014-11-06 10889.57 未披露 定期报告 2014-09-30
2014-08-06 10436.95 未披露 定期报告 2014-08-01
2014-08-06 10130.98 未披露 定期报告 2014-06-30
2014-05-08 9327.45 未披露 定期报告 2014-05-02
2014-04-30 9038.27 未披露 定期报告 2014-04-16
2014-05-08 8759.40 未披露 定期报告 2014-03-31
2014-03-11 8543.56 未披露 定期报告 2014-03-06
2014-03-11 8523.25 未披露
更多>>
from December 31, 2012 to December 31, 2013 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Forfeitures of restricted common shares Exercise of stock options
2013-12-31
2013-11-04 6910.75 未披露 定期报告 2013-10-31
2013-11-04 6910.31 未披露 定期报告 2013-09-30
2013-08-01 6905.91 未披露 定期报告 2013-06-30
2013-04-30 6913.35 未披露 定期报告 2013-04-26
2013-04-30 6913.00 未披露 定期报告 2013-03-31
2013-04-29 6905.50 未披露 定期报告 2013-03-01
2013-03-14 6893.01 未披露
更多>>
from December 31, 2011 to December 31, 2012 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Exercise of stock options Purchase and retirement of common shares from an officer
2012-12-31
2012-11-06 6190.09 未披露 定期报告 2012-11-01
2012-11-06 6188.11 未披露 定期报告 2012-09-30
2012-08-02 6184.35 未披露 定期报告 2012-07-27
2012-08-02 5781.30 未披露 定期报告 2012-06-30
2012-05-03 5763.91 未披露 定期报告 2012-03-31
2012-02-22 5762.49 未披露 定期报告 2012-02-17
2012-02-22 4953.98 未披露
更多>>
from Dec 31,2010 to Dec 31,2011 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Exercise of stock options Forfeitures of restricted common shares
2011-12-31
2011-11-03 4949.84 未披露 定期报告 2011-09-30
2011-08-04 4949.50 未披露 定期报告 2011-07-29
2011-08-04 4947.31 未披露 定期报告 2011-06-30
2011-05-05 4943.68 未披露 定期报告 2011-05-02
2011-05-05 4221.05 未披露 定期报告 2011-03-31
2011-03-11 4216.68 未披露 定期报告 2011-03-04
2011-03-11 4209.02 未披露
更多>>
from dec 31 2009 to dec 31 2010 Issuance of common shares in equity offering, net Issuance of common shares to a related party, net Issuance of restricted common shares Exercise of stock options Forfeitures of restricted common shares
2010-12-31
2010-11-04 4055.41 未披露 定期报告 2010-10-29
2010-11-04 4054.18 未披露 定期报告 2010-09-30
2010-08-09 4054.69 未披露 定期报告 2010-08-06
2010-08-09 4050.44 未披露 定期报告 2010-06-30
2010-05-04 4048.71 未披露 定期报告 2010-04-30
2010-05-04 4048.44 未披露 定期报告 2010-03-31
From June 30, 2025 to September 30, 2025 Issuance of common stock under equity plans
From March 31, 2025 to June 30, 2025 Issuance of common stock under equity plans
From December 31, 2024 to March 31, 2025 Issuance of common stock under equity plans
From December 31, 2023 to December 31, 2024 Issuance of common shares in equity offerings, excluding to related parties, net of transaction costs Sale of warrants and common shares to related parties and exercise of common stock options, net of transaction costs
From June 30, 2024 to September 30, 2024 Sale of common shares to related parties and exercise of common stock options, net of transaction costs
From March 31, 2024 to June 30, 2024 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
From December 31, 2023 to March 31, 2024 Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs Sale of warrants to related parties in equity offerings, exercise of common stock options, and restricted stock vesting, net of transaction costs
Common stock offered 750,000 shares by the company
From December 31, 2022 to December 31, 2023 Issuance of common and preferred shares in equity offerings, excluding to related parties, net of transaction costs Sale of warrants and common shares to related parties and exercise of common stock options, net of transaction costs
Common stock offered 1,248,098 shares by the company
From June 30, 2023 to September 30, 2023 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
From March 31, 2023 to June 30, 2023 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
From December 31, 2022 to March 31, 2023 Sale of common shares to related parties and exercise of common stock options, net of transaction costs
From December 31, 2021 to December 31, 2022 Issuance of common and preferred shares in equity offerings, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
Series B Convertible Preferred Stock offered by the company 400,000 shares Common stock offered by the company 44,444 shares
From December 31, 2020 to December 31, 2021 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
From June 30, 2021 to September 30, 2021 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Exercise of common stock options
From March 31, 2021 to June 30, 2021 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs
From December 31, 2020 to March 31, 2021 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Exercise of common stock options
From December 31, 2019 to December 31, 2020 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
From June 30, 2020 to September 30, 2020 Exercise of common stock options
From March 31, 2020 to June 30, 2020 Exercise of common stock options
from June 30, 2019 to September 30, 2019 Exercise of common stock options
From March 31, 2019 to June 30, 2019 Exercise of common stock options
from December 31, 2018 to March 31, 2019 Exercise of common stock options
from December 31, 2017 to December 31, 2018 Issuance of common shares in equity offering, excluding to related parties, net of transaction costs Sale of common shares to related parties and exercise of common stock options, net of transaction costs
from December 31, 2016 to December 31, 2017 Issuance of common and preferred shares in equity offerings, net of transaction costs
from December 31, 2015 to December 31, 2016 Conversion of convertible notes and related accrued interest to common stock Retirement of restricted stock Acquisition of Synta Issuance of shares to financial advisors in connection with Merger Issuance of restricted common shares Issuance of common shares in equity offering, net of transaction costs
On July 22, 2016, prior to the closing of the merger, Synta completed a one-for-35 reverse stock split. As a result of the reverse stock split, every 35 shares of Synta common stock outstanding immediately prior to the merger were combined and reclassified into one share of Synta common stock. n connection with the merger, Synta changed its name to Madrigal Pharmaceuticals, Inc. The combined company will commence trading on a post-reverse stock split basis upon the opening of trading on July 25, 2016 on the NASDAQ Global Market under the symbol “MDGL”.
From December 31, 2014 to September 30, 2015 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Forfeitures of restricted common shares
from December 31, 2013 to December 31, 2014 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Forfeitures of restricted common shares Exercise of stock options
from December 31, 2012 to December 31, 2013 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Forfeitures of restricted common shares Exercise of stock options
from December 31, 2011 to December 31, 2012 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Exercise of stock options Purchase and retirement of common shares from an officer
from Dec 31,2010 to Dec 31,2011 Issuance of common shares in equity offering, excluding to related parties, net Issuance of common shares to related parties Issuance of restricted common shares Exercise of stock options Forfeitures of restricted common shares
from dec 31 2009 to dec 31 2010 Issuance of common shares in equity offering, net Issuance of common shares to a related party, net Issuance of restricted common shares Exercise of stock options Forfeitures of restricted common shares